Sbir topic 294 phase I - development of glycosylation - specific research
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201100072C
- Awardee
-
Nectagen Inc. UEI KAFMLCY56WM3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,993
Award facts
- Contract value 100% obligated
- $149,993.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 14 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rosedale, KS 66103, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $149,993 |
About this award
This federal contract award, HHSN261201100072C, was made by the National Cancer Institute (a civilian agency) to Nectagen Inc., a small business manufacturer of goods. The $149,993 fixed-price contract is for Nectagen to conduct Phase I SBIR (Small Business Innovation Research) research and development on the "Development of Glycosylation-Specific Research" under Topic 294. The contract has a completion date of December 14, 2012 and was awarded on September 15, 2011. Nectagen is a for-profit S corporation that specializes in innovative biotechnology solutions, particularly related to their "nanoclamp" antibody-mimetic technology, which has applications in areas like affinity chromatography, toxin neutralization, and single-cell analysis. This SBIR Phase I award supports Nectagen's ongoing R&D efforts to advance their core nanoclamp platform for various biomedical and pharmaceutical applications.
Quick answers
Who was awarded contract HHSN261201100072C?
HHSN261201100072C was awarded to Nectagen Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2011.
How much is contract HHSN261201100072C worth?
The government has obligated $149,993 on HHSN261201100072C.
Was contract HHSN261201100072C competed?
The extent of competition for HHSN261201100072C was full and open competition after exclusion of sources. The government received 14 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award